Drugs / InnoLak
last change Apr 2012 re-read 3 minutes ago

InnoLak

Developed for
cervical cancer
Investigated by
Korea Cancer Center Hospital

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01194609 Sep 2010 → Sep 2011 cervical cancer Korea Cancer Center Hospital Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as InnoLak “InnoLak two consecutive weeks every 3 weeks for 3 times” NCT01194609 ↗